Radiopharmaceuticals (RPP) are diagnostic or therapeutic agents containing radioactive nuclides. Diagnostic radiopharmaceuticals are used to study the anatomical and topographic condition or to assess the function of various organs and systems of the body. The effect of therapeutic radiopharmaceuticals on the pathological process is due, unlike conventional biol drugs, to the effect of radionuclide radiation.
RADIONUCLIDE PREPARATIONS
RADIONUCLIDE PREPARATION STRONTIUM-90 (Sr-90)
Application:
The Sr-90 solution is intended for the preparation of working solutions.
Description:
Solutions are supplied in packages ranging from 0.01 to 10 cm(3).
In sealed vessels in the form of vials or ampoules.
Radionuclide:
Sr-90
Half-life:
Sr-90: 28.79 years Y-90: 64.1 hours
Beta particle energy:
β 562 keV (200%)
β1 546 keV (100%)
β2 2274 keV (100%)
All sources based on Sr-90 contain an equilibrium amount of the daughter isotope.
RADIONUCLIDE PREPARATION IODINE-125 (I-125)
Application:
The I-125 solution is intended for the preparation of working solutions.
Description:
Solutions are supplied in packages ranging from 0.01 to 10 cm(3).
In sealed vessels in the form of vials or ampoules.
Radionuclide:
I-125
Half-life:
59,407 days
Photon energy:
XK 27.4 keV (133.7%)
XK 31.2 keV (25.8%)
γ 35.5 keV (6.7%)
RADIONUCLIDE PREPARATION TRITIUM (H3)
Application:
The H-3 solution is intended for the preparation of working solutions.
Description:
Solutions are supplied in packages ranging from 0.01 to 10 cm(3).
In sealed vessels in the form of vials or ampoules.
Radionuclide:
H-3
Half-life:
12.32 years old
βmax 18.59 keV
β 5.69 keV